Search Page

1

Cite

Share

Occupational exposure to conventional antineoplastic drugs: can it be further limited?

Simon N, Odou P, Décaudin B, Bonnabry P, Fleury Souverain S. Simon N, et al. Among authors: decaudin b. Eur J Hosp Pharm. 2020 Sep;27(5):251-252. doi: 10.1136/ejhpharm-2019-002165. Epub 2019 Dec 16. Eur J Hosp Pharm. 2020. PMID: 32839255 No abstract available.

Cite

Share

2

Cite

Share

[Reaction during dalbavancin infusion: About one case].

Valentin B, Dartus J, Trouillez T, Gaboriau L, Loiez C, Dezèque H, Odou P, Décaudin B, Migaud H, Genay S, Senneville E. Valentin B, et al. Among authors: decaudin b. Therapie. 2020 Jul 8:S0040-5957(20)30120-7. doi: 10.1016/j.therap.2020.06.015. Online ahead of print. Therapie. 2020. PMID: 32723578 French. No abstract available.

Cite

Share

3

Cite

Share

Instability of Insulin Aspart Diluted in Dextrose.

Préta LH, Henry H, Masse M, Barthélémy C, Carta N, Foulon C, Goossens JF, Kouach M, Lannoy D, Storme L, Décaudin B, Genay S, Odou P. Préta LH, et al. Among authors: decaudin b. Diabetes Care. 2020 Jul;43(7):e77-e78. doi: 10.2337/dc19-2462. Epub 2020 May 7. Diabetes Care. 2020. PMID: 32381586 No abstract available.

Cite

Share

4

Cite

Share

Long-term stability of ready-to-use 1-mg/mL midazolam solution.

Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P. Gilliot S, et al. Among authors: decaudin b. Am J Health Syst Pharm. 2020 Apr 27;77(9):681-689. doi: 10.1093/ajhp/zxaa040. Am J Health Syst Pharm. 2020. PMID: 32300788

Cite

Share

5

Cite

Share

Efficiency of degradation or desorption methods in antineoplastic drug decontamination: A critical review.

Simon N, Odou P, Decaudin B, Bonnabry P, Fleury-Souverain S. Simon N, et al. Among authors: decaudin b. J Oncol Pharm Pract. 2019 Jun;25(4):929-946. doi: 10.1177/1078155219831427. Epub 2019 Feb 20. J Oncol Pharm Pract. 2019. PMID: 30786823 Review.

Cite

Share

6

Cite

Share

Chemical Decontamination of Hazardous Drugs: A Comparison of Solution Performances.

Simon N, Odou P, Decaudin B, Bonnabry P, Fleury-Souverain S. Simon N, et al. Among authors: decaudin b. Ann Work Expo Health. 2020 Feb 20;64(2):114-124. doi: 10.1093/annweh/wxz093. Ann Work Expo Health. 2020. PMID: 31848570

Cite

Share

7

Cite

Share

Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.

Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P. Masse M, et al. Among authors: decaudin b. Eur J Hosp Pharm. 2020 Mar;27(e1):e87-e92. doi: 10.1136/ejhpharm-2019-002076. Epub 2020 Feb 5. Eur J Hosp Pharm. 2020. PMID: 32296513 Free PMC article. No abstract available.

Cite

Share

8

Cite

Share

Clinical implications of intravenous drug incompatibilities in critically ill patients.

Benlabed M, Perez M, Gaudy R, Genay S, Lannoy D, Barthélémy C, Odou P, Lebuffe G, Décaudin B. Benlabed M, et al. Among authors: decaudin b. Anaesth Crit Care Pain Med. 2019 Apr;38(2):173-180. doi: 10.1016/j.accpm.2018.04.003. Epub 2018 Apr 19. Anaesth Crit Care Pain Med. 2019. PMID: 29680262 Review.

Cite

Share

9

Cite

Share

Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unit.

Petit O, Saint-Lorant G, Vasseur M, Boucher J, Courtin J, Pinturaud M, Allorge D, Decaudin B, Simon N, Odou P. Petit O, et al. Among authors: decaudin b. J Oncol Pharm Pract. 2020 Dec;26(8):2038-2041. doi: 10.1177/1078155220915961. Epub 2020 Apr 11. J Oncol Pharm Pract. 2020. PMID: 32281518

Cite

Share

10

Cite

Share

Polypharmacy in older patients: identifying the need for support by a community pharmacist.

Beuscart JB, Petit S, Gautier S, Wierre P, Balcaen T, Lefebvre JM, Kambia N, Bertoux E, Mascaut D, Barthélémy C, Cuny D, Puisieux F, Décaudin B. Beuscart JB, et al. Among authors: decaudin b. BMC Geriatr. 2019 Oct 21;19(1):277. doi: 10.1186/s12877-019-1276-y. BMC Geriatr. 2019. PMID: 31638909 Free PMC article.

Cite

Share